Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HYPK
(Huntingtin Yeast Partner K) was originally identified by yeast two-hybrid assay as an interactor of Huntingtin, the protein mutated in Huntington's disease.
HYPK
was characterized earlier as an intrinsically unstructured protein having chaperone-like activity in vitro and in vivo.
HYPK
has the ability of reducing rate of aggregate formation and subsequent toxicity caused by mutant Huntingtin. Further investigation revealed that
HYPK
is involved in diverse cellular processes and required for normal functioning of cells. In this study we observed that hyperthermia increases
HYPK
expression in human and mouse cells in culture. Expression of exogenous Heat Shock Factor 1 (HSF1), upon heat treatment could induce
HYPK
expression, whereas HSF1 knockdown reduced endogenous as well as heat-induced
HYPK
expression. Putative HSF1-binding site present in the promoter of human
HYPK
gene was identified and validated by reporter assay. Chromatin immunoprecipitation revealed in vivo interaction of HSF1 and
RNA polymerase II
with
HYPK
promoter sequence. Additionally, acetylation of histone H4, a known epigenetic marker of inducible HSF1 binding, was observed in response to heat shock in
HYPK
gene promoter. Overexpression of
HYPK
inhibited cells from lethal heat-induced death whereas knockdown of
HYPK
made the cells susceptible to lethal heat shock-induced death. Apart from elevated temperature,
HYPK
was also upregulated by hypoxia and proteasome inhibition, two other forms of cellular stress. We concluded that chaperone-like protein
HYPK
is induced by cellular stress and under transcriptional regulation of HSF1.
...
PMID:Transcription regulation of HYPK by Heat Shock Factor 1. 2446 98